TREATMENTS &
RESEARCH

Search the
latest
treatment
information
here.

Dr. Huntley's
Diagnosis
Checklist

Have a symptom?
See what questions
a doctor would ask.

Diseases » Chondrosarcoma » Clinical Trials

Clinical Trials for Chondrosarcoma

Clinical trials are research studies conducted in an effort to improve overall patient health and care. Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition. Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks. A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.

A brief description of each phase:

Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
Phase IV: These studies monitor long-term side effects after the treatment has been marketed.

Clinical Trials data for Chondrosarcoma is grouped into the following categories:-

View by trial name

View by drugs used in Chondrosarcoma clinical trials

Clinical Trials by trial name

The format for each of the following is:

The name of the trial,
followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
followed by a list of drug/s, if any, used in the trial

ClinicalTrials.gov has listed the following trials for Chondrosarcoma:

Phase II Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas - This study is currently recruiting patients (Current: 23 Nov 2006) - Perifosine
Ifosfamide in Treating Patients With Meningeal Tumors - This study has been suspended (Current: 23 Nov 2006) - ifosfamide
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - doxorubicin hydrochloride,ifosfamide
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer - This study has been completed (Current: 23 Nov 2006) - carboplatin,filgrastim,thiotepa,topotecan
Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - ecteinascidin 743
Penclomedine in Treating Patients With Solid Tumors or Lymphoma - This study has been completed (Current: 23 Nov 2006) - penclomedine
Decitabine in Treating Patients With Melanoma or Other Advanced Cancer - This study has been completed (Current: 23 Nov 2006) - decitabine
Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma - This study has been completed (Current: 23 Nov 2006)
Combination Chemotherapy in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - fluorouracil,leucovorin calcium,topotecan
L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - L-778,123
Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - interferon alfa,interleukin-12
Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - amifostine,carboplatin,etoposide,filgrastim,ifosfamide
Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors - This study has been completed (Current: 23 Nov 2006) - irinotecan,LY231514
Combination Chemotherapy in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - fluorouracil,leucovorin calcium,SCH 66336
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - amifostine,carboplatin,cyclophosphamide,sargramostim
Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas - This study is no longer recruiting patients (Current: 23 Nov 2006) - L-778,123,L-778,123/paclitaxel,paclitaxel
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma - This study has been completed (Current: 23 Nov 2006) - 17-N-allylamino-17-demethoxygeldanamycin
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - docetaxel,filgrastim,gemcitabine
Interleukin-2 and Interleukin-12 in Treating Patients With Refractory or Advanced Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - aldesleukin,interleukin-12
Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,cyclophosphamide,dactinomycin,doxorubicin,epirubicin,etoposide,filgrastim,ifosfamide,vincristine
Thalidomide and Docetaxel in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - docetaxel,thalidomide
Alanosine in Treating Patients With Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - alanosine
Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma - This study is currently recruiting patients (Current: 23 Nov 2006) - docetaxel,filgrastim,gemcitabine hydrochloride,pegfilgrastim
Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - celecoxib
Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone - This study is currently recruiting patients (Current: 23 Nov 2006)
Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma - This study is currently recruiting patients (Current: 23 Nov 2006) - pemetrexed disodium
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases - This study is no longer recruiting patients (Current: 23 Nov 2006) - Imatinib mesylate
Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma - This study is currently recruiting patients (Current: 23 Nov 2006) - interferon alfa-2b,sodium stibogluconate
Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma - This study is currently recruiting patients (Current: 23 Nov 2006) - doxorubicin hydrochloride,ifosfamide
Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - glutamine
Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - polyvinylpyrrolidone-sodium hyaluronate gel
Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - heparin,minocycline-EDTA
Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - temozolomide
FR901228 in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma - This study is currently recruiting patients (Current: 23 Nov 2006) - FR901228

Drugs used in Clinical Trials for Chondrosarcoma

The format for each of the following is:

The drug,
followed by the name of the trial,
followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.

ClinicalTrials.gov has listed the following drugs in trials for Chondrosarcoma: